• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗HIV杀微生物剂开发的天然宿主防御肽的作用机制及修饰

Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development.

作者信息

Eade Colleen R, Wood Matthew P, Cole Alexander M

机构信息

Department of Molecular Biology and Microbiology, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL 32816, USA.

出版信息

Curr HIV Res. 2012 Jan 1;10(1):61-72. doi: 10.2174/157016212799304580.

DOI:10.2174/157016212799304580
PMID:22264047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4270272/
Abstract

Despite advances in the treatment of HIV infection, heterosexual transmission of HIV remains high, and vaccines to prevent HIV acquisition have been unfruitful. Vaginal microbicides, on the other hand, have demonstrated considerable potential for HIV prevention, and a variety of compounds have been screened for their activity and safety as anti-HIV microbicides. Among these are the naturally occurring host defense peptides, small peptides from diverse lineages with intrinsic antiviral activity. Naturally occurring host defense peptides with anti-HIV activity are promising candidates for vaginal microbicide development. Their structural variance and accompanying mechanistic diversity provide a wide range of inhibitors whose antiviral activity can be exerted at nearly every stage of the HIV lifecycle. Additionally, peptide modification has been explored as a method for improving the anti-HIV activity of host defense peptides. Structure- and sequence-based alterations have achieved varying success in improving the potency and specificity of anti-HIV peptides. Overall, peptides have been discovered or engineered to inhibit HIV with therapeutic indices of > 1000, encouraging their advancement toward clinical trials. Here we review the naturally occurring anti-HIV host defense peptides, demonstrating their breadth of mechanistic diversity, and exploring approaches to enhance and optimize their activity in order to expedite their development as safe and effective anti-HIV vaginal microbicides.

摘要

尽管在HIV感染治疗方面取得了进展,但HIV的异性传播率仍然很高,预防HIV感染的疫苗也未取得成效。另一方面,阴道杀菌剂已显示出在预防HIV方面具有相当大的潜力,并且已经筛选了多种化合物作为抗HIV杀菌剂的活性和安全性。其中包括天然存在的宿主防御肽,这些来自不同谱系的小肽具有内在的抗病毒活性。具有抗HIV活性的天然宿主防御肽是开发阴道杀菌剂的有希望的候选者。它们的结构差异和相应的机制多样性提供了广泛的抑制剂,其抗病毒活性几乎可以在HIV生命周期的每个阶段发挥作用。此外,肽修饰已被探索作为提高宿主防御肽抗HIV活性的一种方法。基于结构和序列的改变在提高抗HIV肽的效力和特异性方面取得了不同程度的成功。总体而言,已发现或设计出治疗指数>1000的抑制HIV的肽,这鼓励它们朝着临床试验方向发展。在这里,我们综述了天然存在的抗HIV宿主防御肽,展示了它们机制多样性的广度,并探索增强和优化其活性的方法,以加快它们作为安全有效的抗HIV阴道杀菌剂的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978d/4270272/fba3c76dda30/nihms641761f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978d/4270272/139c9593f64f/nihms641761f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978d/4270272/fba3c76dda30/nihms641761f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978d/4270272/139c9593f64f/nihms641761f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/978d/4270272/fba3c76dda30/nihms641761f2.jpg

相似文献

1
Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development.用于抗HIV杀微生物剂开发的天然宿主防御肽的作用机制及修饰
Curr HIV Res. 2012 Jan 1;10(1):61-72. doi: 10.2174/157016212799304580.
2
Clinical development of microbicides for the prevention of HIV infection.用于预防艾滋病毒感染的杀微生物剂的临床开发。
Curr Pharm Des. 2004;10(3):315-36. doi: 10.2174/1381612043386374.
3
Past, present, and future of entry inhibitors as HIV microbicides.作为HIV杀微生物剂的进入抑制剂的过去、现在与未来。
Curr HIV Res. 2012 Jan 1;10(1):19-26. doi: 10.2174/157016212799304616.
4
Animal models for microbicide studies.用于杀微生物剂研究的动物模型。
Curr HIV Res. 2012 Jan 1;10(1):79-87. doi: 10.2174/157016212799304715.
5
Combination of antiretroviral drugs as microbicides.抗逆转录病毒药物联合用作杀菌剂。
Curr HIV Res. 2012 Jan 1;10(1):53-60. doi: 10.2174/157016212799304652.
6
Ex vivo models of HIV sexual transmission and microbicide development.HIV性传播的体外模型与杀微生物剂研发
Curr HIV Res. 2012 Jan 1;10(1):73-8. doi: 10.2174/157016212799304661.
7
Microbicides: a new hope for HIV prevention.杀微生物剂:预防 HIV 的新希望。
Indian J Med Res. 2011 Dec;134(6):939-49. doi: 10.4103/0971-5916.92639.
8
Vaginal microbicides and the prevention of HIV transmission.阴道杀菌剂与HIV传播的预防
Lancet Infect Dis. 2008 Nov;8(11):685-97. doi: 10.1016/S1473-3099(08)70254-8.
9
Vaginal microbicides and their delivery platforms.阴道杀菌剂及其传递平台。
Expert Opin Drug Deliv. 2014 May;11(5):723-40. doi: 10.1517/17425247.2014.888055. Epub 2014 Feb 8.
10
Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.基于抗逆转录病毒药物的杀微生物剂预防HIV-1性传播。
Annu Rev Med. 2008;59:455-71. doi: 10.1146/annurev.med.59.061206.112737.

引用本文的文献

1
Peptide-Based Antiviral Drugs.基于肽的抗病毒药物。
Adv Exp Med Biol. 2021;1322:261-284. doi: 10.1007/978-981-16-0267-2_10.
2
Fejerlectin, a Lectin-like Peptide from the Skin of , Inhibits HIV-1 Entry by Targeting Gp41.费耶尔凝集素,一种源自[生物名称]皮肤的凝集素样肽,通过靶向糖蛋白41抑制HIV-1进入。
ACS Omega. 2021 Feb 24;6(9):6414-6423. doi: 10.1021/acsomega.1c00033. eCollection 2021 Mar 9.
3
Antiviral Activities of Human Host Defense Peptides.人源宿主防御肽的抗病毒活性。
Curr Med Chem. 2020;27(9):1420-1443. doi: 10.2174/0929867326666190805151654.
4
Transcripts of antibacterial peptides in chicken erythrocytes infected with Marek's disease virus.感染马立克氏病病毒的鸡红细胞中抗菌肽的转录本
BMC Vet Res. 2018 Nov 21;14(1):363. doi: 10.1186/s12917-018-1678-7.
5
Comparative Analysis of the Integument Transcriptomes between Mutant and Wild-Type Silkworms.突变型和野生型家蚕表皮转录组的比较分析。
Int J Mol Sci. 2018 Oct 14;19(10):3158. doi: 10.3390/ijms19103158.
6
Antiviral mechanisms of human defensins.人防御素的抗病毒机制。
J Mol Biol. 2013 Dec 13;425(24):4965-80. doi: 10.1016/j.jmb.2013.09.038. Epub 2013 Oct 2.
7
A cholesterol tag at the N terminus of the relatively broad-spectrum fusion inhibitory peptide targets an earlier stage of fusion glycoprotein activation and increases the peptide's antiviral potency in vivo.N 端胆固醇标签靶向相对广谱融合抑制肽的早期融合糖蛋白激活阶段,并提高体内该肽的抗病毒效力。
J Virol. 2013 Aug;87(16):9223-32. doi: 10.1128/JVI.01153-13. Epub 2013 Jun 26.
8
A compensatory mutation provides resistance to disparate HIV fusion inhibitor peptides and enhances membrane fusion.一种补偿性突变提供了对不同 HIV 融合抑制剂肽的抗性,并增强了膜融合。
PLoS One. 2013;8(2):e55478. doi: 10.1371/journal.pone.0055478. Epub 2013 Feb 5.
9
Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.通过在适应性进化位点的精氨酸突变增强人α-防御素 5 对单纯疱疹病毒 2 的抗病毒活性。
J Virol. 2013 Mar;87(5):2835-45. doi: 10.1128/JVI.02209-12. Epub 2012 Dec 26.
10
The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosa.抗 HIV 杀微生物剂候选物 RC-101 可抑制致病阴道细菌而不伤害内源性菌群或黏膜。
Am J Reprod Immunol. 2013 Feb;69(2):150-8. doi: 10.1111/aji.12036. Epub 2012 Nov 20.

本文引用的文献

1
Ureaplasma urealyticum and Mycoplasma hominis sensitivity to bacteriocins produced by two Lactobacilli strains.解脲脲原体和人型支原体对两种乳杆菌产生的细菌素的敏感性。
Curr Microbiol. 2011 Oct;63(4):360-5. doi: 10.1007/s00284-011-9989-y. Epub 2011 Jul 30.
2
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.经阴道传播的 HIV 预防疫苗:一种新型重组乳酸杆菌的活体应用。
Mucosal Immunol. 2011 Nov;4(6):648-57. doi: 10.1038/mi.2011.30. Epub 2011 Jul 6.
3
A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice.一种 CCR5 拮抗剂马拉维若的局部外用杀微生物剂凝胶配方可预防人源化 RAG-hu 小鼠的 HIV-1 阴道传播。
PLoS One. 2011;6(6):e20209. doi: 10.1371/journal.pone.0020209. Epub 2011 Jun 1.
4
Effects of cathelicidin and its fragments on three key enzymes of HIV-1.抗菌肽及其片段对 HIV-1 三种关键酶的影响。
Peptides. 2011 Jun;32(6):1117-22. doi: 10.1016/j.peptides.2011.04.017. Epub 2011 Apr 22.
5
Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.随机、安慰剂对照的 2 期临床试验,评估阴道内给予卷曲乳杆菌益生菌预防复发性尿路感染的效果。
Clin Infect Dis. 2011 May;52(10):1212-7. doi: 10.1093/cid/cir183. Epub 2011 Apr 14.
6
Bacterial membrane lipids in the action of antimicrobial agents.抗菌药物作用下的细菌膜脂。
J Pept Sci. 2011 May;17(5):298-305. doi: 10.1002/psc.1319. Epub 2010 Nov 30.
7
The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1.聚阴离子型人类免疫缺陷病毒 1 抑制剂的兴起与衰落。
Antiviral Res. 2011 Jun;90(3):168-82. doi: 10.1016/j.antiviral.2011.03.176. Epub 2011 Mar 23.
8
Grifonin-1: a small HIV-1 entry inhibitor derived from the algal lectin, Griffithsin.格里福林-1:一种源自海藻凝集素 Griffithsin 的 HIV-1 进入抑制剂小分子。
PLoS One. 2010 Dec 16;5(12):e14360. doi: 10.1371/journal.pone.0014360.
9
The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques.经阴道应用于恒河猴后,配方型杀微生物剂 RC-101 具有安全性和抗病毒活性。
PLoS One. 2010 Nov 29;5(11):e15111. doi: 10.1371/journal.pone.0015111.
10
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.男男性行为人群 HIV 预防的暴露前药物预防。
N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.